Combination lipid-lowering therapy as first-line strategy in very high-risk patients.

Ray, Kausik KReeskamp, Laurens FLaufs, UlrichBanach, MaciejMach, FrançoisTokgözoğlu, Lale SConnolly, DerekGerrits, Anja JStroes, Erik S GMasana, LuisKastelein, John J P2024-09-022024-09-022022-02-22Ray, K. K., Reeskamp, L. F., Laufs, U., Banach, M., Mach, F., Tokgözoğlu, L. S., Connolly, D. L., Gerrits, A. J., Stroes, E. S. G., Masana, L., & Kastelein, J. J. P. (2022). Combination lipid-lowering therapy as first-line strategy in very high-risk patients. European heart journal, 43(8), 830–833.1522-964510.1093/eurheartj/ehab71834636884http://hdl.handle.net/20.500.14200/5596No abstract availableenCardiologyCombination lipid-lowering therapy as first-line strategy in very high-risk patients.ArticleEuropean Heart Journal